Gonadotropin-Dependent Precocious Puberty: Neoplastic Causes and Endocrine Considerations
Author(s) -
Matthew D. Stephen,
Peter E. Zage,
StevenG Waguespack
Publication year - 2011
Publication title -
international journal of pediatric endocrinology
Language(s) - English
Resource type - Journals
eISSN - 1687-9856
pISSN - 1687-9848
DOI - 10.1155/2011/184502
Subject(s) - precocious puberty , medicine , gonadotropin , human chorionic gonadotropin , endocrine system , hypothalamic–pituitary–gonadal axis , etiology , central precocious puberty , population , endocrinology , bioinformatics , hormone , luteinizing hormone , biology , environmental health
Premature activation of the hypothalamic-pituitary-gonadal (HPG) axis manifests as gonadotropin-dependent precocious puberty. The mechanisms behind HPG activation are complex and a clear etiology for early activation is often not elucidated. Though collectively uncommon, the neoplastic and developmental causes of gonadotropin-dependent precocious puberty are very important to consider, as a delay in diagnosis may lead to adverse patient outcomes. The intent of the current paper is to review the neoplastic and developmental causes of gonadotropin-dependent precocious puberty. We discuss the common CNS lesions and human chorionic gonadotropin-secreting tumors that cause sexual precocity, review the relationship between therapeutic radiation and gonadotropin-dependent precocious puberty, and finally, provide an overview of the therapies available for height preservation in this unique patient population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom